期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

药物洗脱支架与冠状动脉搭桥术对糖尿病合并冠脉三支病变的疗效及费用对比研究 被引量：3

下载PDF
导出
摘要 目的比较糖尿病合并冠脉三支病变患者行冠脉介入(PCI)与冠状动脉搭桥术(CABG)两种血运重建方式疗效及费用。方法回顾性分析2007年4月～2009年4月中国医科大学附属第一医院糖尿病合并冠脉三支病变接受血运重建患者的临床资料,根据血运重建方式分为PCI组(81例)及CABG组(70例)。结果住院期间PCI组主要心脑血管不良事件(MACCE)与CABG组比较无统计学差异(P>0.05)。随访1 a,PCI组MACCE事件高于CABG组(P<0.05);术后伤口疼痛均发生在CABG组(P<0.01);术后抗血小板及他汀类药物的应用PCI组高于CABG组(P<0.01),CABG组硝酸酯应用高于PCI组(P<0.01);住院治疗的总费用CABG组高于PCI组(P<0.01)。结论糖尿病合并冠脉三支病变患者采用药物洗脱支架进行血运重建,效果并不次于冠脉搭桥。
作者 孙宇姣 田文 高远 于海杰 姜大明 齐国先
机构地区 中国医科大学附属第一医院
出处 《山东医药》 CAS 2012年第4期62-64,共3页 Shandong Medical Journal
关键词 糖尿病 冠状动脉三支病变 冠状动脉搭桥术 药物洗脱支架
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献7

  • 1Sabate M, Jimenez-Quevedo P, Angiolillo D J, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent ( DIABETES ) trial [ J ]. Circulation, 2005,112(14) :2175-2183.
  • 2Mercado N, Wijns W, Serruys PW, et al. One-year outcomes ofcoronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials [J]. J Thorac Cardiovasc Surg, 2005,130(2) :512-519.
  • 3Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/ AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography [J]. J Am Coil Cardiol, 2009,53 (6) :530-553.
  • 4Lincoff AM. Importance triad in cardiovascular medicine: Diabetes, coronary intervention, and platelet glycoprotein Ⅱ b/Ⅲ a receptorblockade[J]. Circulation, 2003,107 ( 11 ) : 1556-1559.
  • 5Yamagata K, Kataoka Y, Kokubu N, et al. A 3-year clinical out- come after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease [ J]. Circ J, 2010,74 (4) :671-678.
  • 6Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia ( Coronary Artery Revascularization in Diabetes) trial [ J]. J Am Coil Cardiol, 2010, 55(5) :432-440.
  • 7Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery [ J ]. Ann Intern Med, 2007,147(10) :703-716.

同被引文献61

引证文献3

二级引证文献8

山东医药
2012年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部